Energy Recovery, Inc.
For the period ended Mar 31, 2026. Filed May 6, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2026 · Filed May 6, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Notes to Condensed Consolidated Financial Statements
Note 1 — Description of Business and Significant Accounting Policies
Energy Recovery, Inc. and its wholly-owned subsidiaries (the “Company” or “Energy Recovery”) designs and manufactures world-
class energy-saving technology for critical infrastructure that communities rely on every day, driving a more resilient and sustainable future.
Leveraging the Company’spressure exchanger technology, which generates little to no emissions when operating, the Company believes its
solutions lower costs, save energy, reduce waste, and minimize emissions for companies across a variety of commercial and industrial
processes. As the world coalesces around the urgent need to address climate change and its impacts, the Company ishelping companies
reduce their energy consumption in their industrial processes, which in turn, reduces their carbon footprint. The Company believes that its
customers do not have to sacrifice quality and cost savings for sustainability and the Company iscommitted to developing solutions that drive
long-term value – both financial and environmental. The Company’s solutions are marketed, sold in, and developed for, the fluid-flow and
gas markets, such as seawater and wastewater desalination, natural gas, chemical processing and CO 2-based refrigeration systems, under
the trademarks ERI®, PX®, Pressure Exchanger®, PX® Pressure Exchanger® (“PX”), Ultra High-Pressure PX, PX G™, PX G1300®,
PX PowerTrain™, AT™, and Aquabold™. The Company owns, manufactures and/or develops its solutions, in whole or in part, inthe United
States of America (the “U.S.”).
Basis of Presentation
The Condensed Consolidated Financial Statements include the accounts of Energy Recovery, Inc. and its wholly-owned subsidiaries.
All intercompany accounts and transactions have been eliminated in consolidation.
The accompanying Condensed Consolidated Financial Statements have been prepared pursuant to the rules and regulations of the
Securities and Exchange Commission (the “SEC”). Certain information and footnote disclosures normally included in the financial statements
prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) have been condensed or omitted pursuant to such rules
and regulations. The December 31, 2025 Condensed Consolidated Balance Sheet was derived from audited financial statements and may
not include all disclosures required by GAAP; however, the Company believes that the disclosures are adequate to make the information
presented not misleading.
The March 31, 2026 unaudited Condensed Consolidated Financial Statements should be read in conjunction with the audited
Consolidated Financial Statements and the notes thereto for the fiscal year ended December 31, 2025 included in the Company’s Annual
Report on Form 10-K filed with the SEC on February 25, 2026 (the “2025 Annual Report”).
The results of operations for the interim periods are not necessarily indicative of the operating results for the full fiscal year or any
future periods.
Reclassifications
Certain prior period amounts have been reclassified in certain notes to the Condensed Consolidated Financial Statements to conform
to the current period presentation.
Use of Estimates
The preparation of Condensed Consolidated Financial Statements, in conformity with GAAP, requires the Company’s management to
make judgments, assumptions and estimates that affect the amounts reported in the Condensed Consolidated Financial Statements and
accompanying notes.
The accounting policies that reflect the Company’s significant estimates and judgments and that the Company believes are the most
critical to aid in fully understanding and evaluating its reported financial results arerevenue recognition; stock-based compensation expense;
equipment useful life and valuation; goodwill valuation and impairment; inventory valuation and allowances, deferred taxes and valuation
allowances on deferred tax assets; and evaluation and measurement of contingencies. Those estimates could change, and as a result,
actual results could differ materially from those estimates.
The Company is not aware of any specific event or circumstance that would require an update to its estimates or judgments or a
revision of the carrying value of its assets or liabilities as of May 6, 2026, the date of issuance of this Quarterly Report on Form 10-Q. These
estimates may change, as new events occur and additional information is obtained. Actual results could differ materially from these
estimates under different assumptions or conditions. The Company undertakes no obligation to publicly update these estimates for any
reason after the date of this Quarterly Report on Form 10-Q, except as required by law.
Significant Accounting Policies
There have beenno material changes to the Company’s significant accounting policies in Note 1, “Description of Business and
Significant Accounting Policies -Significant Accounting Policies,” of the Notes to Consolidated Financial Statements included in Item 8,
“Financial Statements and Supplementary Data,” of the 2025 Annual Report.
Recently Adopted Accounting Pronouncement
In July 2025, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update 2025-05, Measurement of
Credit Losses for Accounts Receivable and Contract Assets (“ASU 2025-05”). ASU 2025-05 provides a practical expedient for measuring
expected credit losses on current accounts receivables and contract assets by assuming that conditions at the balance sheet date remain
unchanged over the life of the asset. The Company adopted ASU 2025-05 on January 1, 2026 and the adoption did not have a material
impact on results of operations, cash flows, or financial condition.
Recently Issued Accounting Pronouncements Not Yet Adopted
There have been no issued accounting pronouncements that have not yet been adopted during thethree months ended March 31,
2026 that apply to the Company other than the pronouncements disclosed in Note 1, “Description of Business and Significant Accounting
Policies -Recently Issued Accounting Pronouncements Not Yet Adopted,” of the Notes to Consolidated Financial Statements included in Item
8, “Financial Statements and Supplementary Data,” of the 2025 Annual Report.
Note 2 —Revenue
Disaggregation of Revenue
The following table presentsthe disaggregated revenues by segment, and within each segment, bygeographical market based on the
customer “shipped to” address, and bychannel customers. Sales and usage-based taxes are excluded from revenues. See Note 9,
“Segment Reporting,”for further discussion related to the Company’s segments.
| Three Months Ended March 31, 2026 · Three Months Ended March 31, 2025 | ||||||||
|---|---|---|---|---|---|---|---|---|
| Desalination · Wastewater · Emerging Technologies · Total · Desalination · Wastewater · Emerging Technologies · Total | ||||||||
| (In thousands) | ||||||||
| Geographical market | ||||||||
| Middle East | $2,506 | $— | $77 | $2,583 | $2,014 | $— | $1 | $2,015 |
| Africa | 196 | — | — | 196 | 866 | — | — | $866 |
| Other | 6,205 | 601 | 121 | 6,927 | 4,879 | 305 | — | $5,184 |
| Total revenue | $8,907 | $601 | $198 | $9,706 | $7,759 | $305 | $1 | $8,065 |
| Channel | ||||||||
| Original equipment manufacturer | $5,866 | $601 | $121 | $6,588 | $3,813 | $188 | $— | $4,001 |
| Aftermarket | 2,677 | — | 77 | 2,754 | 3,910 | 117 | 1 | $4,028 |
| Megaproject | 364 | — | — | 364 | 36 | — | — | $36 |
| Total revenue | $8,907 | $601 | $198 | $9,706 | $7,759 | $305 | $1 | $8,065 |
Contract Balances
The following table presents contract balances by category.
| March 31,2026 | December 31,2025 | |
|---|---|---|
| (In thousands) | ||
| Accounts receivable, net | $38,941 | $76,639 |
| Contract assets, current (included in prepaid expenses and other assets) | $1,701 | $1,647 |
| Contract liabilities: | ||
| Contract liabilities, current | $1,080 | $1,039 |
| Total contract liabilities | $1,080 | $1,039 |
Contract Liabilities
The Company records contract liabilities, which consist of customer deposits and deferred revenue, when cash payments are
received in advance of the Company’s performance. The following table presents the change in contract liability balances during the reported
periods.
| March 31,2026 | December 31,2025 | |
|---|---|---|
| (In thousands) | ||
| Contract liabilities, beginning of year | $1,039 | $571 |
| Revenue recognized | (462) | (297) |
| Cash received, excluding amounts recognized as revenue during the period | 503 | 765 |
| Contract liabilities, end of period | $1,080 | $1,039 |
Remaining Performance Obligations
As of March 31, 2026, the following table presents the revenue that is expected to be recognized related to performance obligations
that are unsatisfied or partially unsatisfied.
| Period | Remaining Performance Obligations |
|---|---|
| (In thousands) | |
| 2026 (remaining nine months) | $10,461 |
| 2027 | 6,587 |
| Total | $17,048 |
Note 3 —Loss Per Share
Net loss for the reported period is divided by the weighted average number of basic and diluted common shares outstanding during
the reported period to calculate the basic and diluted loss per share, respectively. Outstanding stock options to purchase common shares,
unvested restricted stock units (“RSUs”), and unvested performance restricted stock units (“PRSUs”) are collectively referred to as “equity
awards.”
Basic loss per share is computed using the weighted average number of common shares outstanding during the period.
Diluted loss per share is computed using the weighted average number of common and potentially dilutive shares outstanding
during the period, using the treasury stock method. Any anti-dilutive effect of equity awards outstanding is not included in the
computation of diluted loss per share.
The following table presents the computation of basic and diluted loss per share.
| Three Months Ended March 31, | ||
|---|---|---|
| 2026 | 2025 | |
| (In thousands, except per share amounts) | ||
| Numerator | ||
| Net loss | $(12,251) | $(9,880) |
| Denominator (weighted average shares) | ||
| Basic and dilutive common shares outstanding | 52,660 | 54,902 |
| Diluted common shares outstanding | 52,660 | 54,902 |
| Loss Per Share | ||
| Basic and dilutive | $ (0.23) | $ (0.18) |
The following table presents the equity awards that are excluded from diluted loss per share because (i) their effect would have been
anti-dilutive, or (ii) the equity awards were contingent upon conditions for issuance which were not satisfied as of March 31, 2026.
| Three Months Ended March 31, | ||
|---|---|---|
| 2026 | 2025 | |
| (In thousands) | ||
| Anti-dilutive equity award shares | 3,305 | 2,806 |
Note 4 —Other Financial Information
Cash, Cash Equivalents and Restricted Cash
The Condensed Consolidated Statements of Cash Flows explain the changes in the total of cash, cash equivalents and restricted
cash. The following table presents a reconciliation of cash, cash equivalents and restricted cash, such as cash amounts deposited in
restricted cash accounts in connection with the Company’s credit cards, reported for each period within the Condensed Consolidated Balance
Sheets and the Condensed Consolidated Statements of Cash Flows that sum to the total of such amounts.
| March 31,2026 | December 31,2025 | March 31,2025 | |
|---|---|---|---|
| (In thousands) | |||
| Cash and cash equivalents | $50,116 | $48,076 | $49,137 |
| Restricted cash, non-current (included in other assets, non-current) | — | — | 131 |
| Total cash, cash equivalents and restricted cash | $50,116 | $48,076 | $49,268 |
Inventories, net
Inventory amounts are stated at the lower of cost or net realizable value, using the first-in, first-out method.
| March 31,2026 | December 31,2025 | |
|---|---|---|
| (In thousands) | ||
| Raw materials | $9,688 | $8,289 |
| Work in process | 6,879 | 6,270 |
| Finished goods | 17,035 | 10,768 |
| Inventories, gross | 33,602 | 25,327 |
| Valuation adjustments for excess and obsolete inventory | (2,716) | (1,067) |
| Inventories, net | $30,886 | $24,260 |
Goodwill
Goodwill is tested for impairment annually in the third quarter of the Company’s fiscal year or more frequently if indicators of potential
impairment exist. The Company monitors the industries in which it operates and reviews its business performance for indicators of potential
impairment. The recoverability of goodwill is measured at the reporting unit level, which represents the operating segment.
In February 2026, the Company wound down operations of the CO 2 retail grocery business within its Emerging Technologies
segment due to a fundamental change in the outlook of the business. The Company considered the wind down to be an indicator of
impairment and performed a quantitative impairment test using the discounted cash flow approach and market approach. Based on the
results of the analysis, the Company determined that the carrying value of the reporting unit exceeded its fair value and recorded an
impairment charge of$1.7 million during thethree months ended March 31, 2026.
Accrued Expenses and Other Liabilities
| March 31,2026 | December 31,2025 | |
|---|---|---|
| (In thousands) | ||
| Accrued expenses and other liabilities, current | ||
| Payroll, benefits, incentives and commissions payable | $5,033 | $6,683 |
| Warranty reserve | 189 | 205 |
| Restructuring accrual | 961 | — |
| Income taxes payable | 2,382 | 2,401 |
| Other accrued expenses and other liabilities | 2,325 | 2,381 |
| Total accrued expenses and other liabilities | 10,890 | 11,670 |
| Other liabilities, non-current | 1,098 | 1,070 |
| Total accrued expenses, and current and non-current other liabilities | $11,988 | $12,740 |
Restructuring
2024 Restructuring Plan
During the fourth quarter of fiscal year 2024, the Company implemented a restructuring plan which included reductions primarily within
the G&A function, in order to lower the Company’soperating cost structure, and to position the Companyfor profitable growth. The Company
recorded a restructuring charge of approximately$2.8 million in total, of which$0.5 million was recorded during thethree months ended
March 31, 2025. The total restructuring charge recorded relates to severance and benefits, including reemployment assistance, for
38 terminated employees, which was approximately 15% of the Company’sworkforce. The restructuring plan was complete as of December
31, 2025. All expenses associated with the Company’srestructuring plan are included in “Restructuring charges” in the Condensed
Consolidated Statements of Operations.
2026 Restructuring Plan
During the first quarter of fiscal year 2026, the Company wound down operations of the CO 2 retail grocery business within its
Emerging Technologies segment due to a fundamental change in the outlook of the business. The Company recorded a restructuring charge
of approximately$1.5 million during thethree months ended March 31, 2026. The restructuring charge recorded relates to severance and
benefits, including reemployment assistance, for 23 terminated employees. In addition, the Company incurred other related charges
associated with the wind down of the CO 2 retail grocery business, including excess and obsolescence reserves taken on CO 2 inventory of
approximately$1.6 million and impairment of goodwill of approximately$1.7 million, whichare included in “Restructuring - inventory reserve”
and “Impairment of goodwill” in the Condensed Consolidated Statements of Operations, respectively. Refer to section Goodwill within this
footnote for additional information. The restr ucturing plan was substantially complete by the end of the first quarter of fiscal year 2026 and the
Company does not expect to incur significant additional expenses related to the restructuring.
The following table presents the change in the Company’s restructuring accrual balances, which is included within Accrued expenses
and other liabilities on the Condensed Consolidated Balance Sheets, during thethree months ended March 31, 2026:
| Severance and Benefits | |
|---|---|
| (In thousands) | |
| Balance, as of December 31, 2024 | $2,476 |
| Restructuring provision, net of adjustments | 313 |
| Cash paid | (2,789) |
| Balance, as of December 31, 2025 | $— |
| Restructuring provision | 1,536 |
| Cash paid | (575) |
| Balance, as of March 31, 2026 | $961 |
Note 5 —Investments and Fair Value Measurements
Fair Value of Financial Instruments
The following table presents the Company’s financial assets measured on a recurring basis by contractual maturity, including pricing
category, amortized cost and fair value. Gross unrealized gains and losses were not material for the periods presented. As of March 31,
2026 and December 31, 2025, the Company hadno financial liabilities andno Level 3 financial assets.
| March 31, 2026 · December 31, 2025 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Pricing Category · AmortizedCost · FairValue · AmortizedCost · FairValue | |||||||||
| (In thousands) | |||||||||
| Cash equivalents | |||||||||
| Money market securities | Level 1 | $17,892 | $17,892 | $11,225 | $11,225 | ||||
| U.S. treasury securities | Level 2 | — | — | 12,952 | 12,955 | ||||
| Total cash equivalents | 17,892 | 17,892 | 24,177 | 24,180 | |||||
| Short-term investments | |||||||||
| U.S. treasury securities | Level 2 | 26,535 | 26,539 | 13,618 | 13,640 | ||||
| Corporate notes and bonds | Level 2 | 9,507 | 9,496 | 13,505 | 13,533 | ||||
| Total short-term investments | 36,042 | 36,035 | 27,123 | 27,173 | |||||
| Long-term investments | |||||||||
| U.S. treasury securities | Level 2 | 955 | 957 | 1,959 | 1,971 | ||||
| Corporate notes and bonds | Level 2 | 5,026 | 5,034 | 6,038 | 6,063 | ||||
| Total long-term investments | 5,981 | 5,991 | 7,997 | 8,034 | |||||
| Total short and long-term investments | 42,023 | 42,026 | 35,120 | 35,207 | |||||
| Total | $59,915 | $59,918 | $59,297 | $59,387 | |||||
Note 6 —Lines of Credit
Credit Agreement
The Company entered into a credit agreement with JPMorgan Chase Bank, N.A. on December 22, 2021 (as amended, the “Credit
Agreement”). The Credit Agreement was amended on January 21, 2026 to extend the expiration date from December 21, 2026 to
January 21, 2031. The Credit Agreement provides a committed revolving credit line of$50.0 million and includes both a revolving loan and a
letters of credit (“LCs”) component.
Under the Credit Agreement, as of March 31, 2026, there wereno revolving loans outstanding. In addition, under the LCs
component, as of March 31, 2026 and December 31, 2025, the Company utilized $20.4 million of the maximum allowable credit line of
$30.0 million, which includes newly issued LCs and previously issued and unexpired stand-by letters of credit (“SBLCs”).
Note 7 —Commitments and Contingencies
Sublease
On March 10, 2025, the Company entered into an agreement to sublease its Katy, Texas operating lease. The sublease commenced
on March 10, 2025 and will expire on December 31, 2029. The sublease is classified as an operating lease and has a remaining lease term
of 3.8 years as of March 31, 2026. Sublease income wasimmaterial during thethree months ended March 31, 2026 and 2025, and is
recorded as a reduction of lease expense in general and administrative within the Company’s Condensed Consolidated Statements of
Operations.
The Company considered the sublease to be an indicator of impairment of the original lease. The Company compared the
undiscounted cash flows from the sublease to the carrying value of the Katy, Texas operating lease, which included the associated right-of-
use asset and leasehold improvements. The Company concluded that the carrying value was not recoverable as it exceeded the estimated
undiscounted cash flows.
The Company calculated the impairment charge by comparing the carrying value of the Katy, Texas operating lease to its fair value,
which was calculated based on the net discounted cash flows associated with the sublease. The Company recorded a total impairment
charge of$0.4 million during thethree months ended March 31, 2025, of which$0.2 million and$0.2 million was recorded against the right-
of-use asset and the associated leasehold improvements, respectively. The allocation of the impairment charge was based on the relative
carrying value of the assets. The impairment charge was recorded in general and administrative within the Company’s Condensed
Consolidated Statements of Operations.
Litigation
From time-to-time, the Company has been named in and subject to various proceedings and claims in connection with its business.
The Company may in the future become involved in litigation in the ordinary course of business, including litigation that could be material to
its business. The Company considers all claims, if any, on a quarterly basis and, based on known facts, assesses whether potential losses
are considered reasonably possible, probable and estimable. Based upon this assessment, the Company then evaluates disclosure
requirements and whether to accrue for such claims in its consolidated financial statements. The Company records a provision for a liability
when it is both probable that a liability has been incurred and the amount of the loss can be reasonably estimated. These provisions are
reviewed at least quarterly and are adjusted to reflect the impacts of negotiations, settlements, rulings, advice of legal counsel and other
information and events pertaining to a particular case. As of March 31, 2026, the Company was not involved in any lawsuits, legal
proceedings or claims that would have a material effect on the Company’s financial position, results of operations, or cash flows. Therefore,
there were no material losses which were probable or reasonably estimable and accordingly, the Company didnot record a provision for
litigation as of March 31, 2026 and December 31, 2025.
Note 8 — Income Taxes
| Three Months Ended March 31, | ||
|---|---|---|
| 2026 | 2025 | |
| (In thousands, except percentages) | ||
| Benefit from income taxes | $(1,775) | $(1,603) |
| Discrete items | (132) | 52 |
| Benefit from income taxes, excluding discrete items | $(1,907) | $(1,551) |
| Effective tax rate | 12.7% | 14.0% |
| Effective tax rate, excluding discrete items | 13.6% | 13.5% |
The Company’s interim periodtax benefit from income taxes is determined using an estimate of itsannual effective tax rate, adjusted
for discrete items, if any, that arise during the period. Each quarter, the Company updates itsestimate of the annual effective tax rate, and if
the estimated annual effective tax rate changes, the Company makesa cumulative adjustment in such period. The Company’squarterly tax
provision and estimate of itsannual effective tax rate are subject to variation due to several factors, including variability in accurately
predicting itspre-tax income or loss and the mix of jurisdictions to which they relate, the applicability of special tax regimes, and changes in
how the Company does business.
For thethree months ended March 31, 2026, the recognized benefit from income taxes resulted from the tax projection based on the
full year forecasted profit and included benefits related to the U.S. federal foreign income andforeign-derived deduction eligible
income (“FDDEI”) federal research and development (“R&D”) tax credit, reduced bycertain permanent differences, such as non-deductible
stock-based compensation.
For the three months ended March 31, 2025, the recognized benefit from income taxes resulted from the tax projection based on the
full year forecasted profit and included benefits related to the U.S. federal foreign-derived intangible income (“FDII”), federal R&D tax credit,
certain permanent differences, such as stock-based compensation shortfalls, and partial release of California valuation allowance.
The effective tax rate excluding discrete items for thethree months ended March 31, 2026, as compared to the prior year, differed
primarily due to lower projected federal R&D tax credits, increased non-deductible officer stock-based compensation, largely offset by
projected higher U.S. FDDEI benefits.
On July 4,2025, the One Big Beautiful Bill (“OBBBA”) Act, which includes a broad range of tax reform provisions, was signed into law
in the United States. During thethree months ended March 31, 2026, the Company recorded its best estimate of the impact of the OBBBA on
the income tax provision. The Company will continue to evaluate the elections available within the OBBBA, which may impact the timing of
permanent and temporary differences within the Company’s tax provision.
Note 9 —Segment Reporting
The Company’s Chief Operating Decision-Maker (“CODM”) is its President and Chief Executive Officer. The Company continues to
monitor and review itssegment reporting structure in accordance with authoritative guidance to determine whether any changes have
occurred that would impact itsreportable segments.
During the three months ended March 31, 2026, the Company changed the composition of its reportable segments to better reflect
how the CODM manages the business. As apart of this change, the Water segment was separated into two segments, the Desalination
segment and the Wastewater segment, as both met the criteria of a reportable segment. Prior periods have been recast to conform to the
current year presentation. The recast of prior year information had no impact on the Company’s Condensed Consolidated Balance Sheets,
Condensed Consolidated Statements of Operations, Condensed Consolidated Statements of Comprehensive Loss or Condensed
Consolidated Statements of Cash Flows.
Segment Definition
Income and type of expense activities that are included in the Desalination, Wastewater and Emerging Technologies segments and
corporate operating expenses are as follows:
Desalination segment: Thecontinued development, sales and support of the PX, hydraulic turbochargers and pumps used in
seawater desalination treatment facilities.
Wastewater segment: The continued development, sales and support of the PX, hydraulic turbochargers and pumps used in
wastewater treatment facilities.
Emerging Technologies segment: Thecontinued development, sales and support of activities related to emerging
technologies, such as the PX G1300 used in industrial and commercial refrigeration applications. In February 2026, the
Company wound down operations of the CO 2 retail grocery business within its Emerging Technologies segment due to a
fundamental change in the outlook of the business. As of the first quarter of fiscal year 2026, the Company has substantially
completed the wind down of the business.
Corporate operating expenses: The corporate expenses include certain unallocated expenses outside of the operating
segments, such as audit and accounting services, legal services, board of director fees and expenses, human resources
activities, information systems activities and other separately managed general expenses not related to the identified
segments.
Thefollowing table presents a summary of the Company’s financial information bysegment, including significant segment expenses,
and corporate operating expenses.
| Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Desalination | Wastewater | Emerging Technologies | Corporate | Total | Desalination | Wastewater | Emerging Technologies | Corporate | Total | |
| (In thousands) | ||||||||||
| Revenue | $8,907 | $601 | $198 | $— | $9,706 | $7,759 | $305 | $1 | $— | $8,065 |
| Cost of revenue | 4,942 | 370 | 60 | — | 5,372 | 3,382 | 179 | 46 | — | 3,607 |
| Restructuring - inventory reserve | — | — | 1,632 | — | 1,632 | — | — | — | — | — |
| Gross profit (loss) | 3,965 | 231 | (1,494) | — | 2,702 | 4,377 | 126 | (45) | — | 4,458 |
| Operating expenses | ||||||||||
| General and administrative | 756 | 981 | 348 | 4,370 | 6,455 | 845 | 728 | 755 | 6,246 | 8,574 |
| Sales and marketing | 2,485 | 1,163 | 858 | 613 | 5,119 | 2,108 | 1,037 | 1,270 | 491 | 4,906 |
| Research and development | 1,616 | 136 | 1,037 | — | 2,789 | 849 | 329 | 1,823 | — | 3,001 |
| Restructuring charges | 335 | 18 | 1,140 | 43 | 1,536 | 107 | 103 | 123 | 206 | 539 |
| Impairment of goodwill | — | — | 1,662 | — | 1,662 | — | — | — | — | — |
| Total operating expenses | 5,192 | 2,298 | 5,045 | 5,026 | 17,561 | 3,909 | 2,197 | 3,971 | 6,943 | 17,020 |
| Operating income (loss) | $(1,227) | $(2,067) | $(6,539) | $(5,026) | $(14,859) | $468 | $(2,071) | $(4,016) | $(6,943) | $(12,562) |
Note 10 —Concentrations
Revenue by Country
The following table presents the Company’s product revenue by country.
| Three Months Ended March 31, | ||
|---|---|---|
| 2026 | 2025 | |
| Product revenue by country:(1) | ||
| Cyprus | 12% | ** |
| Egypt | 12% | ** |
| India | ** | 18% |
| Others(2) | 76% | 82% |
| Total | 100% | 100% |
**Zero or less than 10%.
(1)Countries representing more than 10% of product revenues for the periods presented.
(2)Countries in the aggregate, individually representing less than 10% of product revenues for the periods presented.
Customer Revenue Concentration
The following table presents the customers that account for 10% or more of the Company’srevenue and their related segment for
each of the periods presented. Although certain customers might account for greater than 10% of the Company’srevenue at any one point in
time, the concentration ofrevenue between a limited number of customers shifts regularly, depending on when revenue is recognized. The
percentages by customer reflect specific relationships or contracts that would concentrate revenue for the periods presented and do not
indicate a trend specific to any one customer.
| Three Months Ended March 31, | |||
|---|---|---|---|
| Segment | 2026 | 2025 | |
| Customer A | Desalination | 13% | ** |
| Customer B | Desalination | ** | 12% |
**Zero or less than 10%.
Note 11 —Stockholders’ Equity
Share Repurchase Programs
The Company’s Board, from time-to-time, has authorized share repurchase programs under which the Company may, at the
discretion of management, repurchase its outstanding common stock in the open market, or in privately negotiated transactions, in
compliance with applicable state and federal securities laws. The timing and amounts of any purchase under the Company’s share
repurchase programs is based on market conditions and other factors including price, regulatory requirements, and capital availability. The
Company accounts for stock repurchases under these programs using the cost method. As of March 31, 2026, the Company has
repurchased 14,927,562 shares of its common stock at an aggregate cost of$176.8 million under all share repurchase programs.
February 2025 Authorization
On February 26, 2025, the Company announced that the Board authorized a share repurchase program under which the Company
may repurchase its outstanding common stock, at the discretion of management, for up to$30.0 million in aggregate cost, which includes
both the share value of the acquired common stock and the fees charged in connection with acquiring the common stock (the “February 2025
Authorization”). On August 19, 2025, the Company concluded all share repurchases under the February 2025 Authorization. Under the
February 2025 Authorization, the Company repurchased 2,183,648 shares at an aggregate cost of$30.0 million.
August 2025 Authorization
On August 6, 2025, the Board announced a share repurchase program under which the Company may repurchase its outstanding
common stock, at the discretion of management, for up to$25.0 million in aggregate cost, which includes both the share value of the
acquired common stock and the fees charged in connection with acquiring the common stock (the “August 2025 Authorization”). The August
2025 Authorization will expire in May 2026. The Company began to purchase under the August 2025 Authorization in August 2025.
The following table presents the share repurchase activities under the August 2025 Authorization as of March 31, 2026.
| Number of Shares Purchased | Average Price Paid per Share(1) | Plan Activity | |
|---|---|---|---|
| (In millions) | |||
| August 2025 Authorization | 25.0 | ||
| Repurchases under August 2025 Authorization | 1,346,869 | $12.07 | (16.3) |
| Remaining amount under August 2025 Authorization | $8.7 | ||
(1)Excluding commissions
May 2026 Authorization
On May 6, 2026, the Company announced that the Board authorized a share repurchase program under which the Company may
repurchase its outstanding common stock, at the discretion of management, for up to$25.0 million in aggregate cost, which includes both the
share value of the acquired common stock and the fees charged in connection with acquiring the common stock (the “May 2026
Authorization”). The May 2026 Authorization will expire in April 2027. The Company expects to begin purchasing under the May 2026
Authorization in May 2026.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.